As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market, with the exception of Pfizer, saw revenue growth in Q318. Leading the way were Baxter, with its integration of the Mallinckrodt portfolio, as well as Ethicon and Integra, while Pfizer posted...
The Hemostats and Sealants Market continues to grow at a steady clip. SmartTRAK projects this market will reach more than $3.5B by 2022E with a five-year CAGR of ~5%.
It’s good news for many, but do you know the real story behind those numbers?
SmartTRAK identifies what’s driving growth in the global Hemostats and Sealants market. In this Market Outlook article, Doug Devens, SmartTRAK's Senior Analyst, Biosurgery, does a deep dive, discussing what’s fueling this growth and reviews the top market trends you need to know for the year ahead.
- Trend #1: Expanding Indications Fuel Increased Adoption of Fibrin Sealants
- Trend #2: Increasing Use of Sealant Patch Products
- Trend #3: New Plant-Based Technologies Gaining Ground
- Trend #4: Biologic Sealants Ready for Bounce Back
DownloadMarket Outlook: Top Trends to Watch in Hemostats and Sealants
Baxter, Ethicon and Integra lead the way...As reported in SmartTRAK’s Financial Dashboard, the US market for Hemostats and Sealants grew +3.8% YoY in Q218, an increase from +3.1% growth rate overall in Q118. Fibrin sealants continue to lead the way with +7.2% YoY growth in Q218, and thrombin hemostats had a very good quarter with +7.2% growth YoY...
Among the many topics covered in the full Q218 Hemostats and Sealants Market Recap are:
- Ethicon Continues to Lead Hemostats and Sealants
- Thrombins Come Back In Hemostats
- Fibrin Continues To Shine In Sealants
- Q218 events in the US Hemostats and Sealants Market
The US market for Hemostats and Sealants recovered in Q417, up +5.0% YoY, in line with historic growth rates. While biologic sealants continue to lag, every other segment grew, led by absorbable hemostats and fibrin sealants.
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 Hemostats & Sealants Market Recap and Financial Dashboard.
As reported in SmartTRAK’s Financial Dashboard, almost every manufacturer competing in the Hemostats and Sealants market saw revenue growth in Q417/FY17, led by Baxter, Ethicon and Cryolife in Q417 and by Baxter and Integra for FY17 ...
By Doug Devens, Senior Analyst Biosurgery
Surprisingly, the US market for Hemostats and Sealants was down vs Q217 and YoY, an anomaly from historic growth rates, primarily due to supply chain disruptions and softness in the thrombin hemostat segment.
BioMedGPS announces expanded coverage of SmartTRAK Business Intelligence for the Surgical Wound Market with the addition of its newest module, US Hemostats & Sealants.